The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease
Open accessThe DOI matches its Crossref record; 131 of the 134 references it cites were found in a registry or an index.
Abstract
The development of culture-independent techniques for microbiological analysis has uncovered the previously unappreciated complexity of the bacterial microbiome at various anatomic sites. The microbiome of the lung has relatively less bacterial biomass when compared with the lower gastrointestinal tract yet displays considerable diversity. The composition of the lung microbiome is determined by elimination, immigration, and relative growth within its communities. Chronic lung disease alters these factors. Many forms of chronic lung disease demonstrate exacerbations that drive disease progression and are poorly understood. Mounting evidence supports ways in which microbiota dysbiosis can influence host defense and immunity, and in turn may contribute to disease exacerbations. Thus, the key to understanding the pathogenesis of chronic lung disease may reside in deciphering the complex interactions between the host, pathogen, and resident microbiota during stable disease and exacerbations. In this brief review we discuss new insights into these labyrinthine relationships.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, the lungs’ surface approximates 1 m2/kg of body weight and is not sterile (108).”
From The microbiome and human cancer (2021) · cites this paper as [108]
In the citing paper
“metabolites produced by the microbiota could have an important immunoregulatory function specifically targeting the IL-1 axis (590, 591).”
From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [590]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Dominguez-Bello, M. G., Costello, E. K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., & Knight, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002601107 · Cited by 4,774
Grice, E. A., & Segre, J. A. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2537 · Cited by 3,143
Gut Microbiota Metabolism of Dietary Fiber Influences Allergic Airway Disease and Hematopoiesis
Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L. P., Harris, N. L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3444 · Cited by 2,862
MICROBIAL ECOLOGY OF THE GASTROINTESTINAL TRACT
Savage, D. C. (1977) · Annual Review of Microbiology · doi:10.1146/annurev.mi.31.100177.000543 · Cited by 2,436
Community study of role of viral infections in exacerbations of asthma in 9–11 year old children
Johnston, S. L., Pattemore, P. K., Sanderson, G., Smith, S., Lampe, F., Josephs, L., Symington, P., Toole, S. O., Myint, S. H., Tyrrell, D. A. J., et al. (1995) · BMJ · doi:10.1136/bmj.310.6989.1225 · Cited by 1,991
Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916
Cited by
Aspergillus fumigatus and Aspergillosis in 2019
Latgé, J.-P., & Chamilos, G. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00140-18 · Cited by 1,400
The microbiome and human cancer
Sepich-Poore, G. D., Zitvogel, L., Straussman, R., Hasty, J., Wargo, J. A., & Knight, R. (2021) · Science · doi:10.1126/science.abc4552 · Cited by 1,332
“For instance, the lungs’ surface approximates 1 m(2) per kg of body weight and is not sterile (108).”
BackgroundCystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
Malhotra, S., Hayes, D., & Wozniak, D. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00138-18 · Cited by 515
Shen, Z., Xiao, Y., Kang, L., Ma, W., Shi, L., Zhang, L., Zhou, Z., Yang, J., Zhong, J., Yang, D., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa203 · Cited by 513
“ated with disease susceptibility and severity [7].”
Targeting the gut and tumor microbiota in cancer
Park, E. M., Chelvanambi, M., Bhutiani, N., Kroemer, G., Zitvogel, L., & Wargo, J. A. (2022) · Nature Medicine · doi:10.1038/s41591-022-01779-2 · Cited by 496
The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases
Zhang, D., Li, S., Wang, N., Tan, H.-Y., Zhang, Z., & Feng, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00301 · Cited by 433
The microbiota–gut–brain axis and neurodevelopmental disorders
Wang, Q., Yang, Q., & Liu, X. (2023) · Protein & Cell · doi:10.1093/procel/pwad026 · Cited by 355
Unexpected guests in the tumor microenvironment: microbiome in cancer
Wong-Rolle, A., Wei, H. K., Zhao, C., & Jin, C. (2021) · Protein & Cell · doi:10.1007/s13238-020-00813-8 · Cited by 313
Emerging roles of bile acids in mucosal immunity and inflammation
Chen, M. L., Takeda, K., & Sundrud, M. S. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0162-4 · Cited by 298
Microbiome effects on immunity, health and disease in the lung
Shukla, S. D., Budden, K. F., Neal, R., & Hansbro, P. M. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.6 · Cited by 287
Bronchiectasis in children: diagnosis and treatment
Chang, A. B., Bush, A., & Grimwood, K. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31554-x · Cited by 276
The lung microbiome regulates brain autoimmunity
Hosang, L., Canals, R. C., van der Flier, F. J., Hollensteiner, J., Daniel, R., Flügel, A., & Odoardi, F. (2022) · Nature · doi:10.1038/s41586-022-04427-4 · Cited by 260
Nguyen, T. T., Kosciolek, T., Maldonado, Y., Daly, R. E., Martin, A. S., McDonald, D., Knight, R., & Jeste, D. V. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2018.09.014 · Cited by 260
“, 2015), cancer (Schwabe and Jobin, 2013), and chronic pulmonary diseases (Budden et al., 2017; O'Dwyer et al., 2016).”
BackgroundBaseline human gut microbiota profile in healthy people and standard reporting template
King, C. H., Desai, H., Sylvetsky, A. C., LoTempio, J., Ayanyan, S., Carrie, J., Crandall, K. A., Fochtman, B. C., Gasparyan, L., Gulzar, N., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0206484 · Cited by 235
“of the ocean are as important for influencing planetary climate as the microbes of gastrointestinal (GI) tracts of cattle [3]; furthermore, new functions are continuously found for the human microbiome [4-6].”
BackgroundOverview and systematic review of studies of microbiome in schizophrenia and bipolar disorder
Nguyen, T. T., Kosciolek, T., Eyler, L. T., Knight, R., & Jeste, D. V. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.01.013 · Cited by 205
“…gastrointestinal (GI) disorders, such as inflammatory bowel disease (Kostic et al., 2014), obesity and metabolic diseases (Bouter et al., 2017; Hartstra et al., 2015), cancer (Schwabe and Jobin, 2013), and chronic pulmonary diseases (Budden et al., 2017; O’Dwyer et al., 2016), to name a few.”
Liang, D., Leung, R. K.-K., Guan, W., & Au, W. W. (2018) · Gut Pathogens · doi:10.1186/s13099-018-0230-4 · Cited by 203
IL-17 in the lung: the good, the bad, and the ugly
Gurczynski, S. J., & Moore, B. B. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00344.2017 · Cited by 202
Self-citationRespiratory microbiome and epithelial interactions shape immunity in the lungs
Invernizzi, R., Lloyd, C. M., & Molyneaux, P. L. (2020) · Immunology · doi:10.1111/imm.13195 · Cited by 193
“65 In chronic pulmonary diseases, an increased mucus production promotes bacterial growth and leads to the formation of zones with low oxygen concentration and high temperature favouring the selection and maintenance of particular bacteria.”
BackgroundObesity as a risk factor for COVID-19: an overview
Alberca, R. W., Oliveira, L. D. M., Branco, A. C. C. C., Pereira, N. Z., & Sato, M. N. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1775546 · Cited by 192
“This is especially important due to the usage of antivirals or antibiotics in COVID-19 patients, as the elimination of some microorganisms from the lungs could further enhance the local immune response and infection (O’Dwyer, Dickson, and Moore 2016).”
BackgroundRole of probiotics to combat viral infections with emphasis on COVID-19
Sundararaman, A., Ray, M., Ravindra, P. V., & Halami, P. M. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10832-4 · Cited by 185
“Lung microbiota may specifically regulate lung immunity or the development of bronchial-associated lymphoid tissue against lung infection (O’Dwyer et al. 2016).”
BackgroundPoh, T. Y., Ali, N. A. B. M., Mac Aogáin, M., Kathawala, M. H., Setyawati, M. I., Ng, K. W., & Chotirmall, S. H. (2018) · Particle and Fibre Toxicology · doi:10.1186/s12989-018-0282-0 · Cited by 169
Mycobacterium tuberculosis: An Adaptable Pathogen Associated With Multiple Human Diseases
Chai, Q., Zhang, Y., & Liu, C. H. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00158 · Cited by 170
Maintaining homeostatic control of periodontal bone tissue
Hathaway‐Schrader, J. D., & Novince, C. M. (2021) · Periodontology 2000 · doi:10.1111/prd.12368 · Cited by 167
Epithelial Barrier Dysfunction in Chronic Respiratory Diseases
Carlier, F. M., de Fays, C., & Pilette, C. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.691227 · Cited by 160
Ashique, S., De Rubis, G., Sirohi, E., Mishra, N., Rihan, M., Garg, A., Reyes, R.-J., Manandhar, B., Bhatt, S., Jha, N. K., et al. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110231 · Cited by 161
Liu, Q., Tian, X., Maruyama, D., Arjomandi, M., & Prakash, A. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00421.2020 · Cited by 161
Naidoo, C., Nyawo, G. R., Wu, B. G., Walzl, G., Warren, R. M., Segal, L. N., & Theron, G. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30501-0 · Cited by 155
Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection
Håkansson, A., Orihuela, C. J., & Bogaert, D. (2018) · Physiological Reviews · doi:10.1152/physrev.00040.2016 · Cited by 142
Gilbert, N. M., O’Brien, V. P., & Lewis, A. L. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006238 · Cited by 121
Ran, Z., An, Y., Zhou, J., Yang, H. J., Zhang, Y., Yang, J., Wang, L., Li, X., Lu, D., Zhong, J. S., et al. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.115987 · Cited by 121
Pathophysiological aspects of Aspergillus colonization in disease
Gago, S., Denning, D. W., & Bowyer, P. (2018) · Medical Mycology · doi:10.1093/mmy/myy076 · Cited by 135
“129 In the same way, long-term antibiotic therapy in cystic fibrosis and chronic granulomatous disease patients is strongly associated with high risk of A. fumigatus colonization.”
BackgroundKell, D. B., & Pretorius, E. (2018) · Biological Reviews · doi:10.1111/brv.12407 · Cited by 110
Su, Y.-C., Jalalvand, F., Thegerström, J., & Riesbeck, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02530 · Cited by 122
“The role of the lung microbiome in the pathogenesis of COPD by influencing host immune response has also been suggested (151, (183) (184) (185) (186) (187) (188) .”
BackgroundAntimicrobial Resistance and Respiratory Infections
Guitor, A. K., & Wright, G. D. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.06.019 · Cited by 152
The Microbiota Regulates Immunity and Immunologic Diseases in Dogs and Cats
Tizard, I. R., & Jones, S. W. (2017) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2017.10.008 · Cited by 132
“Deeper in the airways, in the lower respiratory tract, Neisseria and gram-negative cocci are common.(18) The lung is not sterile.”
Influence of Intratumor Microbiome on Clinical Outcome and Immune Processes in Prostate Cancer
Ma, J., Gnanasekar, A., Lee, A., Li, W. T., Haas, M., Wang-Rodriguez, J., Chang, E. Y., Rajasekaran, M., & Ongkeko, W. M. (2020) · Cancers · doi:10.3390/cancers12092524 · Cited by 100
Mahmud, S., Al-Mustanjid, M., Akter, F., Rahman, M. S., Ahmed, K., Rahman, M. H., Chen, W., & Moni, M. A. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab115 · Cited by 113
“DIRAS1 is a Protein Coding gene, and DIRAS1 was observed in COPD [65, 66].”
BackgroundEarly life antibiotic use and the risk of asthma and asthma exacerbations in children
Ahmadizar, F., Vijverberg, S. J. H., Arets, H. G. M., de Boer, A., Turner, S., Devereux, G. S., Arabkhazaeli, A., Soares, P., Mukhopadhyay, S., Garssen, J., et al. (2017) · Pediatric Allergy and Immunology · doi:10.1111/pai.12725 · Cited by 94
“1,24,25 The healthy gut microbiome is highly diverse and can be disturbed by environmental factors, for example, antibiotic therapy.”
Kyo, M., Nishioka, K., Nakaya, T., Kida, Y., Tanabe, Y., Ohshimo, S., & Shime, N. (2019) · Respiratory Research · doi:10.1186/s12931-019-1203-y · Cited by 99
Role of microbiota on lung homeostasis and diseases
Wang, J., Li, F., & Tian, Z. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9151-1 · Cited by 106
“The microbiotas in human body primarily include six phyla: Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria, Fusobacteria, and Cyanobacteria (Cui et al., 2014; O'Dwyer et al., 2016) .”
BackgroundGupta, N., Kumar, R. K., & Agrawal, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00709 · Cited by 104
O'Dwyer, D. N., Ashley, S. L., & Moore, B. B. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00221.2016 · Cited by 88
Self-citationHost-Microbiome Interaction in Lung Cancer
Dong, Q., Chen, E. S., Zhao, C. N., & Jin, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.679829 · Cited by 102
“Emerging evidence has linked local dysbiosis with both acute and chronic pulmonary diseases (25).”
BackgroundOutbreak of COVID-19: An emerging global pandemic threat
Peng, M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110499 · Cited by 108
Lung inflammation and disease: A perspective on microbial homeostasis and metabolism
Méndez, R., Banerjee, S., Bhattacharya, S. K., & Banerjee, S. (2018) · IUBMB Life · doi:10.1002/iub.1969 · Cited by 95
Lung microbiome alterations in NSCLC patients
Zheng, L., Sun, R., Zhu, Y., Li, Z., She, X., Jian, X., Yu, F., Deng, X., Sai, B., Wang, L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91195-2 · Cited by 98
Gupta, S., Shariff, M., Chaturvedi, G., Sharma, A., Goel, N., Yadav, M., Mortensen, M. S., Sørensen, S. J., Mukerji, M., & Chauhan, N. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-83524-2 · Cited by 84
Exhaled breath condensate biomarkers for lung cancer
Campanella, A., Summa, S. D., & Tommasi, S. (2019) · Journal of Breath Research · doi:10.1088/1752-7163/ab2f9f · Cited by 91
Neisseria species as pathobionts in bronchiectasis
Li, L., Aogáin, M. M., Xu, T., Jaggi, T. K., Chan, L., Qu, J., Wei, L., Liao, S., Cheng, H. S., Keir, H. R., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.08.005 · Cited by 100
“Departing from traditional single pathogen-centric models to more holistic and integrative approaches will facilitate an appreciation of the airway microbiome composition and its associated host response (Budden et al., 2019; O’Dwyer et al., 2016).”
BackgroundInvernizzi, R., Wu, B. G., Barnett, J. L., Ghai, P., Kingston, S., Hewitt, R. J., Feary, J. R., Li, Y., Chua, F., Wu, Z., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202002-0460oc · Cited by 88
“It is increasingly recognized that a reciprocal communication likely exists between the microbiome and the pulmonary immune system, which may be critical for promoting pathology in a number of respiratory conditions (40).”
BackgroundFacciponte, D. N., Bough, M. W., Seidler, D., Carroll, J. L., Ashare, A., Andrew, A. S., Tsongalis, G. J., Vaickus, L. J., Henegan, P. L., Butt, T. H., et al. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.07.226 · Cited by 81
Functional lower airways genomic profiling of the microbiome to capture active microbial metabolism
Sulaiman, I., Wu, B. G., Li, Y., Tsay, J.-C. J., Sauthoff, M., Scott, A. S., Ji, K., Koralov, S. B., Weiden, M. D., Clemente, J. C., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.03434-2020 · Cited by 84
Proal, A. D., & Marshall, T. G. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00373 · Cited by 89
“These include the lungs, the bladder, the placenta, the testes, and the uterus [ (19, (30) (31) (32) (33) ].”
BackgroundChoreño-Parra, J. A., Thirunavukkarasu, S., Zúñiga, J., & Khader, S. A. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.04.004 · Cited by 77
“Nonetheless, infection and disease progression is prevented by the innate pulmonary defense mechanisms [1] .”
Maes, M., Kanchanatawan, B., Sirivichayakul, S., & Carvalho, A. F. (2019) · Neurotoxicity Research · doi:10.1007/s12640-018-9987-y · Cited by 73
Sekyere, J. O., Maningi, N. E., & Fourie, P. B. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14300 · Cited by 81
The gut microbiome is a significant risk factor for future chronic lung disease
Liu, Y., Teo, S. M., Méric, G., Tang, H. H. F., Zhu, Q., Sanders, J. G., Vázquez‐Baeza, Y., Verspoor, K. M., Vartiainen, V. A., Jousilahti, P., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.12.810 · Cited by 79
Respiratory microbiome in mechanically ventilated patients: a narrative review
Fromentin, M., Ricard, J.-D., & Roux, D. (2021) · Intensive Care Medicine · doi:10.1007/s00134-020-06338-2 · Cited by 81
Yüksel, N., Gelmez, B., & Yıldız-Peköz, A. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00323 · Cited by 81
The Human Microbiome and Understanding the 16S rRNA Gene in Translational Nursing Science
Ames, N. J., Ranucci, A., Moriyama, B., & Wallen, G. R. (2017) · Nursing Research · doi:10.1097/nnr.0000000000000212 · Cited by 71
Chen, Y., Fan, L., Chai, Y., & Xu, J. (2022) · The Clinical Respiratory Journal · doi:10.1111/crj.13538 · Cited by 83
“Notably, in theory, contamination with commensal oral flora organisms seems to be inescapable.(67) Without a standardized protocol, it is difficult for clinicians to interpret the results of metagenomic sequencing.”
BackgroundPervizaj-Oruqaj, L., Ferrero, M. R., Matt, U., & Herold, S. (2024) · European Respiratory Review · doi:10.1183/16000617.0263-2023 · Cited by 83
“These multifaceted signals arise from the alveolar epithelium and are further shaped by acute or chronic inflammatory stimuli such as damage-associated molecular patterns, PAMPs and cytokines, toxic agents, microbiome composition, and nutrient availability and composition [79, 80].”
BackgroundHost responses to mucosal biofilms in the lung and gut
Domingue, J. C., Drewes, J. L., Merlo, C. A., Housseau, F., & Sears, C. L. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0270-1 · Cited by 67
Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges
Ailioaie, L. M., & Litscher, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094942 · Cited by 75
Relationship between nasopharyngeal microbiota and patient’s susceptibility to viral infection
Dubourg, G., Edouard, S., & Raoult, D. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1621168 · Cited by 72
“tence of the dogma of lung sterility [13,23] and the difficulty to”
BackgroundMore of the Gut in the Lung: How Two Microbiomes Meet in ARDS.
Mukherjee, S., & Hanidziar, D. (2018) · Europe PMC (PubMed Central) · Cited by 70
Li, S., Simoni, Y., Becht, É., Loh, C. Y., Li, N., Lachance, D. M., Koo, S., Lim, T. P., Tan, E., Mathew, R., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100039 · Cited by 80
Selway, C. A., Eisenhofer, R., & Weyrich, L. S. (2020) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.151 · Cited by 77
“For example, research has shown that microbes colonise and perform critical functions within the lungs, albeit at low concentrations [44].”
BackgroundMicrobiota and Immunity during Respiratory Infections: Lung and Gut Affair
Marrella, V., Nicchiotti, F., & Cassani, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074051 · Cited by 79
“Indeed, a continuous dialog between commensal bacteria and resident epithelial and immune cells support the lung homeostasis [5].”
Neill, S., & Dean, N. C. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000524 · Cited by 74
Jaggupilli, A., Singh, N., de Jesus, V. C., Duan, K., & Chelikani, P. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00094 · Cited by 61
Bastos, R. W., Valero, C., Silva, L. P., Schoen, T., Drott, M., Brauer, V., Silva-Rocha, R., Lind, A., Steenwyk, J. L., Rokas, A., et al. (2020) · mSphere · doi:10.1128/msphere.00153-20 · Cited by 60
Microbiota and Tuberculosis: A Potential Role of Probiotics, and Postbiotics
Liu, Y., Wang, J., & Wu, C. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.626254 · Cited by 64
Lung Dysbiosis, Inflammation, and Injury in Hematopoietic Cell Transplantation
O’Dwyer, D. N., Zhou, X., Wilke, C. A., Xia, M., Falkowski, N. R., Norman, K. C., Arnold, K. B., Huffnagle, G. B., Murray, S., Erb‐Downward, J. R., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2456oc · Cited by 63
Self-citationGenetic influences on viral-induced cytokine responses in the lung
Forbester, J. L., & Humphreys, I. R. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00355-6 · Cited by 59
“IMPACT OF INFLAMMATION ON PULMONARY VIRAL INFECTIONS The primary role of the lung is gas exchange and oxygen delivery, which are fundamental processes for host survival, but also leave the lung vulnerable to pathogens due to constant exposure to the external environment.(1) Therefore, the lung provides a difficult imm…”
BackgroundThe Lung Microbiome: A New Frontier for Lung and Brain Disease
Chen, J., Li, T., Ye, C., Zhong, J., Huang, J., Ke, Y., & Sun, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032170 · Cited by 60
Microglia promote maladaptive plasticity in autonomic circuitry after spinal cord injury in mice
Brennan, F. H., Swarts, E. A., Kigerl, K. A., Mifflin, K. A., Guan, Z., Noble, B. T., Wang, Y., Witcher, K. G., Godbout, J. P., & Popovich, P. G. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adi3259 · Cited by 60
“We noted that the bacterial composition in sham control and sham + microglia depletion mice was similar and included Citrobacter (small, dark, with red halo) and Enterococcus (turquoise blue), which are not typically pathogenic in healthy lungs ( 43 ) (Fig.”
BackgroundThe Role of Bacterial and Fungal Human Respiratory Microbiota in COVID‐19 Patients
Soltani, S., Zakeri, A., Zandi, M., Kesheh, M. M., Tabibzadeh, A., Dastranj, M., Faramarzi, S., Didehdar, M., Hafezi, H., Hosseini, P., et al. (2021) · BioMed Research International · doi:10.1155/2021/6670798 · Cited by 54
Mucus, Microbiomes and Pulmonary Disease
Meldrum, O. W., & Chotirmall, S. H. (2021) · Biomedicines · doi:10.3390/biomedicines9060675 · Cited by 58
“The gut microbiome including its role in regulating host metabolism is well studied; however, gaps exist in understanding the identity, abundance, and functionality of the lung microbiome in the setting of chronic respiratory disease [12,59].”
BackgroundBiofilm and Cancer: Interactions and Future Directions for Cancer Therapy
Choi, E., Murray, B., & Choi, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612836 · Cited by 62
The innate immune architecture of lung tumors and its implication in disease progression
Milette, S., Fiset, P., Walsh, L. A., Spicer, J. D., & Quail, D. F. (2019) · The Journal of Pathology · doi:10.1002/path.5241 · Cited by 58
“The lungs are also host to commensal microorganisms and exposed to exogenous inorganic and organic particulates during respiration [6].”
BackgroundLung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer
Carbone, C., Piro, G., Noia, V. D., D’Argento, E., Vita, E., Ferrara, M. G., Pilotto, S., Milella, M., Cammarota, G., Gasbarrini, A., et al. (2019) · Mediators of Inflammation · doi:10.1155/2019/7652014 · Cited by 56
“The specific composition of the lung microbiome results from the balance of three phenomena: microbial immigration, microbial elimination, and the relative reproduction rates of its members [55].”
BackgroundTamburro, R. F., Cooke, K. R., Davies, S. M., Goldfarb, S., Hagood, J. S., Srinivasan, A., Steiner, M. E., Stokes, D. C., DiFronzo, N. L., El-Kassar, N., et al. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202001-006ot · Cited by 57
Host-microbe interactions in the pathogenesis and clinical course of sarcoidosis
Inaoka, P. T., Shono, M., Kamada, M., & Espinoza, J. L. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0537-6 · Cited by 56
“Although gut microbiota is the most studied human microbiota niche, well-defined microbiota communities have been identified in virtually any body niche, including the skin and the respiratory tract [24, 53, 111].”
BackgroundSARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections
Cyprian, F. S., Sohail, M. U., Abdelhafez, I., Salman, S., Attique, Z., Kamareddine, L., & Al‐Asmakh, M. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.02.071 · Cited by 52
Sepsis roadmap: What we know, what we learned, and where we are going
Kumar, V. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.108264 · Cited by 53
Species-level evaluation of the human respiratory microbiome
Ibironke, O. A., McGuinness, L. R., Lu, S., Wang, Y., Hussain, S., Weisel, C. P., & Kerkhof, L. J. (2020) · GigaScience · doi:10.1093/gigascience/giaa038 · Cited by 49
Milross, L., Majo, J., Cooper, N., Kaye, P. M., Bayraktar, O. A., Filby, A. J., & Fisher, A. J. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00408-2 · Cited by 47
Risk factors for recurrent respiratory tract infection in preschool-aged children
Zhou, B., Niu, W., Liu, F., Yuan, Y., Wang, K., Zhang, J., Wang, Y., & Zhang, Z. (2020) · Pediatric Research · doi:10.1038/s41390-020-01233-4 · Cited by 74
Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection
El‐Mowafy, M., Elgaml, A., El‐Mesery, M., Sultan, S., Ahmed, T. A., Gomaa, A. I., Aly, M., & Mottawea, W. (2021) · Biology · doi:10.3390/biology10010055 · Cited by 52
Dogs’ Microbiome From Tip to Toe
Pereira, A. M., & Clemente, A. (2021) · Topics in companion animal medicine · doi:10.1016/j.tcam.2021.100584 · Cited by 60
Lee, S. Y., Aogáin, M. M., Fam, K. D., Chia, K. L., Ali, N. A. B. M., Yap, M. M. C., Yap, P. H., Chotirmall, S. H., & Lim, C. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225636 · Cited by 47
“Microbial diversity thus negatively correlated with lung function in our study, which contrasted with respiratory disease states where positive correlation is generally observed [50, 51].”
ResultAllali, I., Bakri, Y., Amzazi, S., & Ghazal, H. (2021) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2021/6655380 · Cited by 48
Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbidities
Smits, P. D., Gratzl, S., Simonov, M., Nachimuthu, S., Cartwright, B. M. G., Wang, M. D., Baker, C., Rodriguez, P., Bogiages, M., Althouse, B. M., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.02.038 · Cited by 49
The Lung Microbiota and Lung Cancer: A Growing Relationship
Zerdan, M. B., Kassab, J. T., Meouchy, P., Haroun, E., Nehme, R., Zerdan, M. B., Fahed, G., Petrosino, M., Dutta, D., & Graziano, S. L. (2022) · Cancers · doi:10.3390/cancers14194813 · Cited by 49
“All of these diseases are characterized by periods of acute exacerbations that can be induced by dysbiosis [12].”
BackgroundInfluentialAlterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients
Tong, X., Su, F., Xu, X., Xu, H., Yang, T., Xu, Q., Dai, H., Huang, K., Zou, L., Zhang, W., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00149 · Cited by 42
“In contrast, culture-independent approaches, primarily based on gene sequencing, better describe the wide diversity of the microbial inhabitants of the lung microbiota and are able to identify significant differences between healthy subjects and patients with various respiratory diseases (Turnbaugh et al., 2007; Huse…”
BackgroundCirculating 16S RNA in Biofluids: Extracellular Vesicles as Mirrors of Human Microbiome?
Ricci, V., Carcione, D., Messina, S., Colombo, G. I., & D’Alessandra, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238959 · Cited by 50
“Similar studies showed that the respiratory microbiota was different during COPD exacerbations compared to periods of clinical stability, proving that the modulation of the microbiota is also related to the stage of the pathology [29].”
ResultMurray, M. P., Engel, I., Seumois, G., de la Mata, S. H., Rosales, S. L., Sethi, A., Premlal, A. L. R., Seo, G., Greenbaum, J., Vijayanand, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21574-w · Cited by 44
Host–microbiome orchestration of the sulfated metabolome
D’Agostino, G. D., Chaudhari, S. N., & Devlin, A. S. (2024) · Nature Chemical Biology · doi:10.1038/s41589-023-01526-9 · Cited by 49
“Cell surface HS on H1299 human lung cells was reduced by 60% upon exposure to cell-free supernatants from mid-log phase cultures of B. ovatus or B. thetaiotaomicron 49–51 .”
The microbiota-mediated dietary and nutritional interventions for COVID-19
Gasmi, A., Tippairote, T., Mujawdiya, P. K., Peana, M., Menzel, A., Dadar, M., Gasmi Benahmed, A., & Bjørklund, G. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108725 · Cited by 42
“The neomycin-induced microbiota imbalance, aka gut dysbiosis, increased the lung infection from influenza virus in the animal models through the inactivation of the inflammasome, dendritic cells, and T-cells responses [55].”
Influential
Metadata
- Authors
- O’Dwyer, D. N., Dickson, R. P., & Moore, B. B.
- Affiliations
- Michigan Medicine (US)
- University of Michigan (US)
- Corresponding author
- Moore, Bethany B
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-06
- Volume
- 196
- Issue
- 12
- Pages
- 4839-4847
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC4894335
- OpenAlex
- W2413745624
- Cited by
- 362
- References
- 134
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 31 · 2023: 39 · 2022: 50 · 2021: 55 · 2020: 65 · 2019: 34 · 2018: 26 · 2017: 15 · 2016: 4
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR000433)
- National Heart, Lung, and Blood Institute (R01HL115618, L30 HL120241, R01HL119682, K23HL130641, R01HL127805, T32HL007749)
- National Institute of Allergy and Infectious Diseases (R01AI117229)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- lung microbiome, chronic lung disease, dysbiosis, lung immunity, disease exacerbation, host-microbe interactions, bacterial diversity, pathogenesis
- MeSH terms
- Bacteria, Chronic Disease, Homeostasis, Humans, Lung, Lung Diseases, Disease Progression, Host-Pathogen Interactions, Microbiota, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.